Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 1
2009 2
2012 1
2013 1
2014 1
2015 4
2016 8
2018 6
2019 3
2020 2
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?
Märtson AG, Sturkenboom MGG, Stojanova J, Cattaneo D, Hope W, Marriott D, Patanwala AE, Peloquin CA, Wicha SG, van der Werf TS, Tängdén T, Roberts JA, Neely MN, Alffenaar JC. Märtson AG, et al. Among authors: sturkenboom mgg. Clin Microbiol Infect. 2020 Aug;26(8):1008-1016. doi: 10.1016/j.cmi.2020.03.008. Epub 2020 Mar 21. Clin Microbiol Infect. 2020. PMID: 32205294 Review.
Therapeutic Drug Monitoring of Posaconazole: an Update.
Dekkers BGJ, Bakker M, van der Elst KCM, Sturkenboom MGG, Veringa A, Span LFR, Alffenaar JC. Dekkers BGJ, et al. Among authors: sturkenboom mgg. Curr Fungal Infect Rep. 2016;10:51-61. doi: 10.1007/s12281-016-0255-4. Epub 2016 May 7. Curr Fungal Infect Rep. 2016. PMID: 27358662 Free PMC article. Review.
Emerging drugs and alternative possibilities in the treatment of tuberculosis.
Hofman S, Segers MM, Ghimire S, Bolhuis MS, Sturkenboom MG, Van Soolingen D, Alffenaar JW. Hofman S, et al. Among authors: sturkenboom mg. Expert Opin Emerg Drugs. 2016;21(1):103-16. doi: 10.1517/14728214.2016.1151000. Epub 2016 Feb 20. Expert Opin Emerg Drugs. 2016. PMID: 26848966 Review.
Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis.
Saktiawati AMI, Harkema M, Setyawan A, Subronto YW, Sumardi, Stienstra Y, Aarnoutse RE, Magis-Escurra C, Kosterink JGW, van der Werf TS, Alffenaar JC, Sturkenboom MGG. Saktiawati AMI, et al. Among authors: sturkenboom mgg. Clin Pharmacokinet. 2019 Nov;58(11):1445-1454. doi: 10.1007/s40262-019-00763-3. Clin Pharmacokinet. 2019. PMID: 30997650 Free PMC article. Clinical Trial.
End TB with precision treatment!
van der Burgt EP, Sturkenboom MG, Bolhuis MS, Akkerman OW, Kosterink JG, de Lange WC, Cobelens FG, van der Werf TS, Alffenaar JW. van der Burgt EP, et al. Among authors: sturkenboom mg. Eur Respir J. 2016 Feb;47(2):680-2. doi: 10.1183/13993003.01285-2015. Eur Respir J. 2016. PMID: 26828056 Free article. No abstract available.
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients.
van den Elsen SHJ, Sturkenboom MGG, Akkerman OW, Manika K, Kioumis IP, van der Werf TS, Johnson JL, Peloquin C, Touw DJ, Alffenaar JC. van den Elsen SHJ, et al. Among authors: sturkenboom mgg. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00384-19. doi: 10.1128/AAC.00384-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 31010868 Free PMC article.
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.
van den Elsen SH, Sturkenboom MG, Akkerman O, Barkane L, Bruchfeld J, Eather G, Heysell SK, Hurevich H, Kuksa L, Kunst H, Kuhlin J, Manika K, Moschos C, Mpagama SG, Muñoz Torrico M, Skrahina A, Sotgiu G, Tadolini M, Tiberi S, Volpato F, van der Werf TS, Wilson MR, Zúñiga J, Touw DJ, Migliori GB, Alffenaar JW. van den Elsen SH, et al. Among authors: sturkenboom mg. BMJ Open. 2020 Jun 16;10(6):e035350. doi: 10.1136/bmjopen-2019-035350. BMJ Open. 2020. PMID: 32554740 Free PMC article.
An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+.
Mieras LF, Taal AT, van Brakel WH, Cambau E, Saunderson PR, Smith WCS, Prakoeswa CRS, Astari L, Scollard DM, do Nascimento DC, Grosset J, Kar HK, Izumi S, Gillini L, Virmond MCL, Sturkenboom MGG. Mieras LF, et al. Among authors: sturkenboom mgg. BMC Infect Dis. 2018 Oct 5;18(1):506. doi: 10.1186/s12879-018-3402-4. BMC Infect Dis. 2018. PMID: 30290790 Free PMC article.
d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.
Deshpande D, Alffenaar JC, Köser CU, Dheda K, Chapagain ML, Simbar N, Schön T, Sturkenboom MGG, McIlleron H, Lee PS, Koeuth T, Mpagama SG, Banu S, Foongladda S, Ogarkov O, Pholwat S, Houpt ER, Heysell SK, Gumbo T. Deshpande D, et al. Among authors: sturkenboom mgg. Clin Infect Dis. 2018 Nov 28;67(suppl_3):S308-S316. doi: 10.1093/cid/ciy624. Clin Infect Dis. 2018. PMID: 30496460 Free PMC article.
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page